These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25859374)

  • 1. Capillary rarefaction: an early marker of microvascular disease in young hemodialysis patients.
    Edwards-Richards A; DeFreitas M; Katsoufis CP; Seeherunvong W; Sasaki N; Freundlich M; Zilleruelo G; Abitbol CL
    Clin Kidney J; 2014 Dec; 7(6):569-74. PubMed ID: 25859374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcirculatory function deteriorates with advancing stages of chronic kidney disease independently of arterial stiffness and atherosclerosis.
    Schoina M; Loutradis C; Memmos E; Dimitroulas T; Pagkopoulou E; Doumas M; Karagiannis A; Garyfallos A; Papagianni A; Sarafidis P
    Hypertens Res; 2021 Feb; 44(2):179-187. PubMed ID: 32728149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal capillary rarefaction as a marker of microvascular damage in patients with rheumatoid arthritis: Association with inflammation and disorders of the macrocirculation.
    Anyfanti P; Gkaliagkousi E; Triantafyllou A; Zabulis X; Dolgyras P; Galanopoulou V; Aslanidis S; Douma S
    Microcirculation; 2018 Jul; 25(5):e12451. PubMed ID: 29734516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary rarefaction in advanced chronic kidney disease is associated with high phosphorus and bicarbonate levels.
    Thang OH; Serné EH; Grooteman MP; Smulders YM; ter Wee PM; Tangelder GJ; Nubé MJ
    Nephrol Dial Transplant; 2011 Nov; 26(11):3529-36. PubMed ID: 21414968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary rarefaction: a missing link in renal and cardiovascular disease?
    Steegh FMEG; Keijbeck AA; de Hoogt PA; Rademakers T; Houben AJHM; Reesink KD; Stehouwer CDA; Daemen MJAP; Peutz-Kootstra CJ
    Angiogenesis; 2024 Feb; 27(1):23-35. PubMed ID: 37326760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational Study.
    van Dinther M; Bennett J; Thornton GD; Voorter PHM; Ezponda Casajús A; Hughes A; Captur G; Holtackers RJ; ; Staals J; Backes WH; Bastarika G; Jones EAV; González A; van Oostenbrugge RJ; Treibel TA
    Cerebrovasc Dis Extra; 2023; 13(1):18-32. PubMed ID: 36646051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals.
    Triantafyllou A; Anyfanti P; Triantafyllou G; Zabulis X; Aslanidis S; Douma S
    J Am Soc Hypertens; 2016 Aug; 10(8):640-6. PubMed ID: 27265366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder.
    Hussain I; Tandi R; Singh G; Kaur G; Abhishek ; Dodda S; Patel D; Natarajan B; Maram T; Kedia A; Vempati R; Sahu S; Choubey U
    Cureus; 2023 Jan; 15(1):e33879. PubMed ID: 36812096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal capillary and arteriolar changes in patients with chronic kidney disease.
    Bosch A; Scheppach JB; Harazny JM; Raff U; Eckardt KU; Schmieder RE; Schneider MP
    Microvasc Res; 2018 Jul; 118():121-127. PubMed ID: 29559377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.
    Bosch AJ; Harazny JM; Kistner I; Friedrich S; Wojtkiewicz J; Schmieder RE
    BMC Cardiovasc Disord; 2017 Dec; 17(1):300. PubMed ID: 29268712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired skeletal muscle performance as a consequence of random functional capillary rarefaction can be restored with overload-dependent angiogenesis.
    Tickle PG; Hendrickse PW; Degens H; Egginton S
    J Physiol; 2020 Mar; 598(6):1187-1203. PubMed ID: 32012275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease.
    Schoina M; Loutradis C; Theodorakopoulou M; Dimitroulas T; Triantafillidou E; Doumas M; Karagiannis A; Garyfallos A; Papagianni A; Sarafidis P
    Microcirculation; 2021 Feb; 28(2):e12665. PubMed ID: 33064902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic microvascular rarefaction is correlated with dysfunction of late endothelial progenitor cells in mild hypertension: a substudy of EXCAVATION-CHN1.
    Liang J; Li Y; Chen L; Xia W; Wu G; Tong X; Su C; He J; Lin X; Tao J
    J Transl Med; 2019 Nov; 17(1):368. PubMed ID: 31718666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension.
    Frost S; Nolde JM; Chan J; Joyson A; Gregory C; Carnagarin R; Herat LY; Matthews VB; Robinson L; Vignarajan J; Prentice D; Kanagasingam Y; Schlaich MP
    Sci Rep; 2021 Jan; 11(1):1001. PubMed ID: 33441624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Kidney Injury, Microvascular Rarefaction, and Estimated Glomerular Filtration Rate in Kidney Transplant Recipients.
    Doreille A; Azzi F; Larivière-Beaudoin S; Karakeussian-Rimbaud A; Trudel D; Hébert MJ; Dieudé M; Patey N; Cardinal H
    Clin J Am Soc Nephrol; 2021 Mar; 16(3):415-426. PubMed ID: 33648972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced systemic microvascular density and reactivity in individuals with early onset coronary artery disease.
    Tibirica E; Souza EG; De Lorenzo A; Oliveira GM
    Microvasc Res; 2015 Jan; 97():105-8. PubMed ID: 25446366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in Regular Hemodialysis Patients.
    Kandarini Y; Mahadita GW; Herawati S; Wibhuti IBR; Widiana IGR; Ayu NP
    Int J Gen Med; 2022; 15():4227-4236. PubMed ID: 35480992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral-bone metabolism markers in young hemodialysis patients.
    Osorio A; Ortega E; Torres JM; Sanchez P; Ruiz-Requena E
    Clin Biochem; 2011 Dec; 44(17-18):1425-8. PubMed ID: 21933667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.